Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

Healthcare Medical Devices
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

SQI Diagnostics Inc > It's time to monetize something...
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(783)
•••
Post by mercedesmanon Aug 24, 2022 11:19am
333 Views
Post# 34917047

It's time to monetize something...

It's time to monetize something...$ 36M USD Market Cap?

For:
  • revolutionary transplant assist technology (in partneship with the UHN, a world-leader in lung transplantation)
  • Rali-Dx (as an ICU Triage tool to predict adverse inflammatory reactions to various infections inclusding Covid-19)
  • perhaps the highest level of accuracy in serum based Covid Antibody testing
  • Home Diagnostics for other hard to diagnose afflictions (RA, Celiac)
  • Efficient/cost saving multi-plexing technology / equipment for the BioTech Industry
  • PCR and asymptomatic Covid testing equipment - all rapid turn-around (jump started by recent merger - in critical industries like mining and film production)
  • Surface detection technology (in partnership with McMaster U)

IMO, any one of the peices could be sold for multiples of the current MC. Collectively, likely > $ 1B USD, if properly packaged and negotiated.

Let's get'r started and get'r done.

MM
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities